Program
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Assembly Biosciences (NQ: ASMB )

12.91 -0.24 (-1.81%)
Streaming Delayed Price Updated: 3:50 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,053
Open 13.03
Bid (Size) 12.71 (6)
Ask (Size) 13.16 (1)
Prev. Close 13.15
Today's Range 12.70 - 13.48
52wk Range 0.6410 - 15.19
Shares Outstanding 52,121,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
From Assembly Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
+1451.86%
+1451.86%
1 Month
-6.23%
-6.23%
3 Month
+1178.37%
+1178.37%
6 Month
+1374.08%
+1374.08%
1 Year
+1141.49%
+1141.49%

More News

Read More
ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023
Via InvestorPlace
Assembly Biosciences Announces Effective Date of Reverse Stock Split
From Assembly Biosciences, Inc.
Via GlobeNewswire
Assembly Biosciences Provides Anticipated Development Milestones for 2024
From Assembly Biosciences, Inc.
Via GlobeNewswire
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Assembly Biosciences, Inc.
Via GlobeNewswire
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
From Assembly Biosciences, Inc.
Via GlobeNewswire
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
From Assembly Biosciences, Inc.
Via GlobeNewswire
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
From Assembly Biosciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Moves Lower; Bank of America Profit Beats Expectations
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Are Stocks Down Today?
Via InvestorPlace
Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?
Via InvestorPlace
Nasdaq Down Over 1%; US Retail Sales Top Expectations
Via Benzinga
Topics Stocks
Exposures US Equities
Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
From Gilead Sciences, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.